- Home
- CTXR vs BLUE Comparison
CTXR vs BLUE Comparison
Compare CTXR & BLUE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CTXR
- BLUE
- Stock Information
- Founded
- CTXR 2007
- BLUE 1992
- Country
- CTXR United States
- BLUE United States
- Employees
- CTXR N/A
- BLUE N/A
- Industry
- CTXR Biotechnology: Pharmaceutical Preparations
- BLUE Biotechnology: Biological Products (No Diagnostic Substances)
- Sector
- CTXR Health Care
- BLUE Health Care
- Exchange
- CTXR Nasdaq
- BLUE Nasdaq
- Market Cap
- CTXR 84.9M
- BLUE 78.7M
- IPO Year
- CTXR N/A
- BLUE 2013
- Fundamental
- Price
- CTXR $2.65
- BLUE $9.34
- Analyst Decision
- CTXR Buy
- BLUE Hold
- Analyst Count
- CTXR 2
- BLUE 9
- Target Price
- CTXR $100.00
- BLUE $49.14
- AVG Volume (30 Days)
- CTXR 561.0K
- BLUE 627.8K
- Earning Date
- CTXR 02-12-2025
- BLUE 11-14-2024
- Dividend Yield
- CTXR N/A
- BLUE N/A
- EPS Growth
- CTXR N/A
- BLUE N/A
- EPS
- CTXR N/A
- BLUE N/A
- Revenue
- CTXR N/A
- BLUE $53,120,000.00
- Revenue This Year
- CTXR N/A
- BLUE $161.01
- Revenue Next Year
- CTXR N/A
- BLUE $221.61
- P/E Ratio
- CTXR N/A
- BLUE N/A
- Revenue Growth
- CTXR N/A
- BLUE 144.50
- 52 Week Low
- CTXR $2.44
- BLUE $5.80
- 52 Week High
- CTXR $26.75
- BLUE $55.60
- Technical
- Relative Strength Index (RSI)
- CTXR 30.59
- BLUE 54.68
- Support Level
- CTXR $2.44
- BLUE $5.97
- Resistance Level
- CTXR $2.85
- BLUE $10.20
- Average True Range (ATR)
- CTXR 0.34
- BLUE 1.81
- MACD
- CTXR 0.15
- BLUE 0.10
- Stochastic Oscillator
- CTXR 24.99
- BLUE 39.24
About CTXR Citius Pharmaceuticals Inc.
Citius Pharmaceuticals Inc is a biopharmaceutical company with a focus on anti-infectives in adjunct cancer care, prescription products, and stem cell therapy. It is currently advancing four proprietary product candidates: LYMPHIR for the treatment of patients with persistent or recurrent cutaneous T-cell lymphoma . Mino-Lok, which is an antibiotic lock solution used to treat patients with catheter-related bloodstream infections; Mino-Wrap, a liquifying gel-based wrap for reduction of tissue expander infections following breast reconstructive surgeries; Halo-Lido, a topical formulation that is intended to provide anti-inflammatory and anesthetic relief to persons suffering from hemorrhoids; NoveCite, a mesenchymal stem cell therapy for the treatment of acute respiratory distress syndrome.
About BLUE bluebird bio Inc.
bluebird bio Inc is a biotechnology company engaged in researching, developing, and commercializing potentially curative gene therapies for severe genetic diseases based on its proprietary lentiviral vector (LVV) gene addition platform. The Company operates in a single segment, focusing on researching, developing and commercializing potentially transformative gene therapies for severe genetic diseases.